Details

NameSymbolSector
AJANTA PHARMA LTD.AJANTPHARMPharmaceuticals
Open
3620.9
High
3700.6
Low
3603.1
Close
3672.8
Volume
95494
Exchange
nse
Time
14-Aug-2026

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Ajanta Pharma is  
Long Body
Estimated Stoploss of Ajanta Pharma is ₹  
3603.1
Ajanta Pharma has a  
Bullishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Ajanta Pharma maybe  
Unpredictableℹ
, but keep a lookout for rise in price. 

Trend

Ajanta Pharma is in  
Sideways trendℹ
. 
Price of Ajanta Pharma is  
Upℹ
 by  

9.7

%. 
Target
Buy @ 

2866.82

Sell @ 

3648.46

Current @ 

3672.8

Volume

The trade volumes of Ajanta Pharma have become  
Deficientℹ
Though the volume trend for Ajanta Pharma appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Ajanta Pharma is  

Down

 by  

47.94

% 

Valuation

The current market price of Ajanta Pharma is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 5014cr and total assets worth ₹ 5014cr, the balance sheet of Ajanta Pharma is:  
Balancedℹ
. 
Cashflow
Ajanta Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 47cr

. It is  
Upℹ
 by  

123.5

%. 

(*Mar 2025)

51.06% i.e. ₹ 1157cr earned in operatingℹ
16.59% i.e. ₹ 376cr spent in investingℹ
32.35% i.e. ₹ 733cr spent in financingℹ
0% in otherℹ
Ajanta Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 200cr

. It is  
Downℹ
 by  

261.29

%. 

(*Mar 2024)

41.29% i.e. ₹ 785cr earned in operatingℹ
3.42% i.e. ₹ 65cr earned in investingℹ
55.29% i.e. ₹ 1051cr spent in financingℹ
0% in otherℹ
Income
The income of Ajanta Pharma is  

₹ 1413cr

 and  

Profit

 is :  

₹ 260cr

(*Sep 2025)

Ajanta Pharma Profit is up by:  

1.96

% and Income is Up by:  

6.4

% 

(*Sep 2025)

The income of Ajanta Pharma is  

₹ 1328cr

 and  

Profit

 is :  

₹ 255cr

(*Jun 2025)

Ajanta Pharma Profit is up by:  

13.33

% and Income is Up by:  

11.78

% 

(*Jun 2025)

The income of Ajanta Pharma is  

₹ 1188cr

 and  

Profit

 is :  

₹ 225cr

(*Mar 2025)

Ajanta Pharma Profit is down by:  

3.02

% and Income is Up by:  

1.02

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.